Serotonin transporter and saitohin genes in risk of Alzheimer's disease and frontotemporal lobar dementia: Preliminary findings

Neurological Sciences

Volumn 31, Issue 6, 2010, Pages 741-749

  Lorenzi, Cristina ^a   Marcone, Alessandra ^b   Pirovano, Adele ^a   Marino, Elena ^a   Cordici, Francesco ^c   Cerami, Chiara ^b   Delmonte, Dario ^a   Cappa, Stefano F ^a   Bramanti, Placido ^c   Smeraldi, Enrico ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Case control study; Dementia; Genetics; Saitohin; Serotonin; Serotonin transporter

Indexed keywords

SAITOHIN; SEROTONIN TRANSPORTER; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE FREQUENCY; GENE INTERACTION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PROMOTER REGION; PROTEIN FUNCTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; FEMALE; FRONTOTEMPORAL DEMENTIA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; MALE; POLYMORPHISM, GENETIC; RISK FACTORS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 78650517131     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-010-0400-8     Document Type: Article

References (77)

1. M Harciarek K Jodzio 2005 Neuropsychological differences between frontotemporal dementia and Alzheimer's disease: a review Neuropsychol Rev 15 131 145 10.1007/s11065-005-7093-4 16328732 (Pubitemid 41674441)
2. JS Snowden D Neary DM Mann 2002 Frontotemporal dementia Br J Psychiatry 180 140 143 10.1192/bjp.180.2.140 11823324 (Pubitemid 34142785)
3. HJ Rosen KM Hartikainen W Jagust JH Kramer BR Reed JL Cummings K Boone W Ellis C Miller BL Miller 2002 Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD Neurology 58 1608 1615 12058087
4. SI Deutsch RB Rosse RM Lakshman 2006 Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of Alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications Prog Neuropsychopharmacol Biol Psychiatry 30 1369 1380 10.1016/j.pnpbp.2006.04. 007 16793187 (Pubitemid 44634940)
5. MG Spillantini M Goedert 1998 Tau protein pathology in neurodegenerative diseases Trends Neurosci 21 428 433 10.1016/S0166-2236(98)01337-X 9786340 (Pubitemid 28449072)
6. I Grundke-Iqbal K Iqbal YC Tung M Quinlan HM Wisniewski LI Binder 1986 Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology Proc Natl Acad Sci USA 83 4913 4917 10.1073/pnas.83.13.4913 3088567
7. M Hong VM Lee 1997 Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons J Biol Chem 272 19547 19553 10.1074/jbc.272.31.19547 9235959 (Pubitemid 27337756)
8. M Hong DC Chen PS Klein VM Lee 1997 Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3 J Biol Chem 272 25326 25332 10.1074/jbc.272.40.25326 9312151 (Pubitemid 27415724)
9. VM Lee M Goedert JQ Trojanowski 2001 Neurodegenerative tauopathies Annu Rev Neurosci 24 1121 1159 10.1146/annurev.neuro.24.1.1121 11520930 (Pubitemid 32695256)
10. GM McKhann MS Albert M Grossman B Miller D Dickson JQ Trojanowski 2001 Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease Arch Neurol 58 1803 1809 10.1001/archneur.58.11.1803 11708987
11. DG Munoz DW Dickson C Bergeron IR Mackenzie A Delacourte V Zhukareva 2003 The neuropathology and biochemistry of frontotemporal dementia Ann Neurol 54 Suppl 5 S24 S28 10.1002/ana.10571 12833365 (Pubitemid 36760150)
12. RV Bhat SL Budd Haeberlein J Avila 2004 Glycogen synthase kinase 3: a drug target for CNS therapies J Neurochem 89 1313 1317 10.1111/j.1471-4159.2004. 02422.x 15189333 (Pubitemid 38802652)
13. A Kertesz P McMonagle M Blair W Davidson DG Munoz 2005 The evolution and pathology of frontotemporal dementia Brain 128 1996 2005 10.1093/brain/awh598 16033782 (Pubitemid 41253267)
14. D Campion C Dumanchin D Hannequin B Dubois S Belliard M Puel C Thomas-Anterion A Michon C Martin F Charbonnier G Raux A Camuzat C Penet V Mesnage M Martinez F Clerget-Darpoux A Brice T Frebourg 1999 Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum Am J Hum Genet 65 664 670 10.1086/302553 10441572 (Pubitemid 30468710)
15. L Bertram RE Tanzi 2008 Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses Nat Rev Neurosci 9 768 778 10.1038/nrn2494 18802446
16. IR Mackenzie R Rademakers 2007 The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments Neurogenetics 8 237 248 10.1007/s10048-007-0102-4 17805587 (Pubitemid 47624449)
17. O Bugiani JR Murrell G Giaccone M Hasegawa G Ghigo M Tabaton M Morbin A Primavera F Carella C Solaro M Grisoli M Savoiardo MG Spillantini F Tagliavini M Goedert B Ghetti 1999 Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau J Neuropathol Exp Neurol 58 667 677 10.1097/00005072-199906000-00011 10374757
18. JR Murrell MG Spillantini P Zolo M Guazzelli MJ Smith M Hasegawa F Redi RA Crowther P Pietrini B Ghetti M Goedert 1999 Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits J Neuropathol Exp Neurol 58 1207 1226 10.1097/00005072-199912000-00002 10604746
19. HR Morris J Perez-Tur JC Janssen J Brown AJ Lees NW Wood J Hardy M Hutton MN Rossor 1999 Mutation in the tau exon 10 splice site region in familial frontotemporal dementia Ann Neurol 45 270 271 10.1002/1531-8249(199902)45: 2<270::AID-ANA22>3.0.CO;2-2 9989634 (Pubitemid 29072380)
20. C Rizzini M Goedert JR Hodges MJ Smith R Jakes R Hills JH Xuereb RA Crowther MG Spillantini 2000 Tau gene mutation K257T causes a tauopathy similar to Pick's disease J Neuropathol Exp Neurol 59 990 1001 11089577
21. R Rademakers M Cruts C van Broeckhoven 2004 The role of tau (MAPT) in frontotemporal dementia and related tauopathies Hum Mutat 24 277 295 10.1002/humu.20086 15365985 (Pubitemid 39336634)
22. AM Palmer GC Stratmann AW Procter DM Bowen 1988 Possible neurotransmitter basis of behavioral changes in Alzheimer's disease Ann Neurol 23 616 620 10.1002/ana.410230616 2457353
23. KJ Reinikainen H Soininen PJ Riekkinen 1990 Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy J Neurosci Res 27 576 586 10.1002/jnr.490270419 1981917
24. Mossner R, Schmitt A, Syagailo Y, Gerlach M, Riederer P, Lesch KP (2000) The serotonin transporter in Alzheimer's and Parkinson's disease. J Neural Transm Suppl 60:345-350
25. AM Kumar M Kumar S Sevush J Ruiz C Eisdorfer 1995 Serotonin uptake and its kinetics in platelets of women with Alzheimer's disease Psychiatry Res 59 145 150 10.1016/0165-1781(95)02786-6 8771229 (Pubitemid 26024511)
26. KP Lesch U Balling J Gross K Strauss BL Wolozin DL Murphy P Riederer 1994 Organization of the human serotonin transporter gene J Neural Transm Gen Sect 95 157 162 10.1007/BF01276434 7865169
27. A Heils A Teufel S Petri G Stöber P Riederer D Bengel P Lesch 1996 Allelic variation of human serotonin transporter gene expression J Neurochem 66 2621 2624 10.1046/j.1471-4159.1996.66062621.x 8632190
28. H Kunugi A Ueki M Otsuka K Isse H Hirasawa N Kato T Nabika S Kobayashi S Nanko 2000 Alzheimer's disease and 5-HTTLPR polymorphism of the serotonin transporter gene: no evidence for an association Am J Med Genet 96 307 309 10.1002/1096-8628(20000612)96:3<307::AID-AJMG14>3.0.CO;2-0 10898905 (Pubitemid 30662490)
29. T Li C Holmes PC Sham H Vallada J Birkett G Kirov KP Lesch J Powell S Lovestone D Collier 1997 Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease Neuroreport 8 683 686 10.1097/00001756-199702100-00021 9106747
30. JRM Oliveira M Zatz 1999 The study of genetic polymorphisms related to serotonin in Alzheimer's disease: new perspective in a heterogenic disorder Braz J Med Biol Res 32 463 467 10347811
31. JRM Oliveira RM Gallindo LGS Maia PR Britomarques PA Otto MR Passosbueno MA Morais M Zatz 1998 The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimers-disease Mol Psychiatry 3 438 441 10.1038/sj.mp.4000417 9774779
32. P Zill F Padberg S de Jonge H Hampel K Burger S Stubner T Boetsch H Jurgen Moller M Ackenheil B Bondy 2000 Serotonin transporter (5-HTT) gene polymorphism in psychogeriatric patients Neurosci Lett 284 113 115 10.1016/S0304-3940(00)00994-0 10771175 (Pubitemid 30193212)
33. F Assal M Alarcon EC Solomon D Masterman DH Geschwind JL Cummings V Klimek G Roberson CA Stockmeier GA Ordway 2004 Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease Arch Neurol 61 1249 1253 10.1001/archneur.61.8.1249 15313842 (Pubitemid 39062679)
34. TM Ha DM Cho SW Park MJ Joo BJ Lee BG Kong JM Kim JS Yoon YH Kim 2005 Evaluating associations between 5-HTTLPR polymorphism and Alzheimer's disease for Korean patients Dement Geriatr Cogn Disord 20 31 34 10.1159/000085071 15832033 (Pubitemid 40981175)
35. D Micheli C Bonvicini A Rocchi R Ceravolo M Mancuso G Tognoni M Gennarelli G Siciliano L Murri 2006 No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease J Alzheimers Dis 10 371 378 17183148
36. B Borroni M Grassi C Agosti S Archetti C Costanzi C Cornali C Caltagirone L Caimi M Di Luca A Padovani 2006 Cumulative effect of COMT and 5-HTTLPR polymorphisms and their interaction with disease severity and comorbidities on the risk of psychosis in Alzheimer disease Am J Geriatr Psychiatry 14 343 351 10.1097/01.JGP.0000192491.50802.c3 16582043
37. D Albani F Prato C Fenoglio S Batelli S Dusi S De Mauro L Polito C Lovati D Galimberti C Mariani E Scarpini G Forloni 2008 Association study to evaluate the serotonin transporter and apolipoprotein E genes in frontotemporal lobar degeneration in Italy J Hum Genet 53 1029 1033 10.1007/s10038-008-0344-5 19020798
38. Borroni B, Grassi M, Agosti C, Premi E, Archetti S, Alberici A, Bellelli G, Caimi L, Di Luca M, Padovani A (2010) Establishing short-term prognosis in frontotemporal lobar degeneration spectrum: role of genetic background and clinical phenotype. Neurobiol Aging 31(2):270-279
39. D Albani F Prato M Tettamanti C Lovati D Galimberti I Restelli C Mariani PL Quadri E Scarpini U Lucca G Forloni 2009 The serotonin transporter promoter polymorphic region is not a risk factor for Alzheimer's disease related behavioral disturbances J Alzheimers Dis 18 125 130 19625753
40. M Hu W Retz M Baader B Pesold G Adler FA Henn M Rosler J Thome 2000 Promoter polymorphism of the 5-HT transporter and Alzheimer's disease Neurosci Lett 294 63 65 10.1016/S0304-3940(00)01544-5 11044587
41. A Serretti P Artioli R Quartesan D De Ronchi 2005 Genes involved in Alzheimer's disease, a survey of possible candidates J Alzheimers Dis 7 331 353 16131736
42. C Conrad C Vianna M Freeman P Davies 2002 A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer's disease Proc Natl Acad Sci USA 99 7751 7756 10.1073/pnas.112194599 12032355 (Pubitemid 34568763)
43. L Buee T Bussiere V Buee-Scherrer A Delacourte PR Hof 2000 Tau protein isoforms, phosphorylation and role in neurodegenerative disorders Brain Res Brain Res Rev 33 95 130 10.1016/S0165-0173(00)00019-9 10967355
44. L Cook CE Brayne D Easton JG Evans J Xuereb NJ Cairns DC Rubinsztein 2002 No evidence for an association between saitohin Q7R polymorphism and Alzheimer's disease Ann Neurol 52 690 691 10.1002/ana.10362 12402275
45. P Verpillat S Ricard D Hannequin B Dubois J Bou A Camuzat L Pradier T Frebourg A Brice F Clerget-Darpoux JF Deleuze D Campion 2002 Is the saitohin gene involved in neurodegenerative diseases? Ann Neurol 52 829 832 10.1002/ana.10384 12447938 (Pubitemid 35403194)
46. LN Clark G Levy MX Tang H Mejia-Santana A Ciappa B Tycko LJ Cote ED Louis R Mayeux K Marder 2003 The Saitohin 'Q7R' polymorphism and tau haplotype in multi-ethnic Alzheimer disease and Parkinson's disease cohorts Neurosci Lett 347 17 20 10.1016/S0304-3940(03)00635-9 12865131 (Pubitemid 36831096)
47. O Combarros L Rodero J Infante E Palacio J Llorca C Fernandez-Viadero N Pena J Berciano 2003 Age-dependent association between the Q7R polymorphism in the saitohin gene and sporadic Alzheimer's disease Dement Geriatr Cogn Disord 16 132 135 10.1159/000071000 12826738 (Pubitemid 36736998)
48. JR Streffer A Papassotiropoulos P Kurosinski A Signorell MA Wollmer M Tsolaki V Iakovidou F Horndli J Bosset J Gotz RM Nitsch C Hock 2003 Saitohin gene is not associated with Alzheimer's disease J Neurol Neurosurg Psychiatry 74 362 363 10.1136/jnnp.74.3.362 12588928 (Pubitemid 36259366)
49. C Conrad C Vianna C Schultz DR Thal E Ghebremedhin J Lenz H Braak P Davies 2004 Molecular evolution and genetics of the saitohin gene and tau haplotype in Alzheimer's disease and argyrophilic grain disease J Neurochem 89 179 188 10.1046/j.1471-4159.2004.02320.x 15030402
50. D Seripa MG Matera RP D'Andrea C Gravina C Masullo A Daniele A Bizzarro M Rinaldi P Antuono DR Wekstein G Dal Forno VM Fazio 2004 Alzheimer disease risk associated with APOE4 is modified by STH gene polymorphism Neurology 62 1631 1633 15136700
51. B Wang S Zhou Z Yang YC Xie J Wang P Zhang Z Lv C Zheng X Ma 2008 Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and saitohin Q7R polymorphisms with Alzheimer's disease J Neurol Sci 270 148 151 10.1016/j.jns.2008.02.021 18396294
52. K Lin M Tang Y Guo H Han Y Lin C Ma 2008 The Q7R polymorphism in the saitohin gene is rare in a southern Chinese population Neurol Sci 29 431 434 10.1007/s10072-008-1014-2 18850062
53. R de Silva A Hope A Pittman ME Weale HR Morris NW Wood AJ Lees 2003 Strong association of the saitohin gene Q7 variant with progressive supranuclear palsy Neurology 61 407 409 12913211
54. M Ezquerra J Campdelacreu E Munoz R Oliva E Tolosa 2004 Sequence analysis of tau 3′untranslated region and saitohin gene in sporadic progressive supranuclear palsy J Neurol Neurosurg Psychiatry 75 155 157 14707330
55. C Levecque A Elbaz J Clavel JS Vidal P Amouyel A Alperovitch C Tzourio MC Chartier-Harlin 2004 Association of polymorphisms in the tau and saitohin genes with Parkinson's disease J Neurol Neurosurg Psychiatry 75 478 480 10.1136/jnnp.2003.015750 14966169 (Pubitemid 38338783)
56. G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 939 944 6610841
57. D Neary JS Snowden L Gustafson U Passant D Stuss S Black M Freedman A Kertesz PH Robert M Albert K Boone BL Miller J Cummings DF Benson 1998 Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria Neurology 51 1546 1554 9855500
58. American Psychiatric Association (2002) Diagnostic and statistical manual of mental disorders, 4th edition revised. American Psychiatric Association, Washington, DC
59. JL Cummings M Mega K Gray S Rosenberg-Thompson DA Carusi J Gornbein 1994 The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia Neurology 44 2308 2314 7991117
60. F Faul E Erdfelder AG Lang A Buchner 2007 G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences Behav Res Methods 39 175 191 17695343
61. KP Lesch D Bengel A Heils SZ Sabol BD Greenberg S Petri J Benjamin CR Muller DH Hamer DL Murphy 1996 Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 274 1527 1531 10.1126/science.274.5292.1527 8929413 (Pubitemid 26403928)
62. KA Vossel BL Miller 2008 New approaches to the treatment of frontotemporal lobar degeneration Curr Opin Neurol 21 708 716 10.1097/WCO.0b013e328318444d 18989117
63. M Goedert CM Wischik RA Crowther JE Walker A Klug 1988 Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau Proc Natl Acad Sci USA 85 4051 4055 10.1073/pnas.85.11.4051 3131773
64. A Andreadis WM Brown KS Kosik 1992 Structure and novel exons of the human tau gene Biochemistry 31 10626 10633 10.1021/bi00158a027 1420178
65. M Goedert MG Spillantini R Jakes D Rutherford RA Crowther 1989 Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease Neuron 3 519 526 10.1016/0896-6273(89)90210-9 2484340
66. M Goedert MG Spillantini MC Potier J Ulrich RA Crowther 1989 Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain EMBO J 8 393 399 2498079
67. P Verpillat A Camuzat D Hannequin C Thomas-Anterion M Puel S Belliard B Dubois M Didic BF Michel L Lacomblez O Moreaud F Sellal V Golfier D Campion F Clerget-Darpoux A Brice 2002 Association between the extended tau haplotype and frontotemporal dementia Arch Neurol 59 935 939 10.1001/archneur.59.6.935 12056929
68. B Peplonska C Zekanowski D Religa K Czyzewski M Styczynska A Pfeffer T Gabryelewicz M Golebiowski E Luczywek B Wasiak A Barczak M Chodakowska M Barcikowska J Kuznicki 2003 Strong association between saitohin gene polymorphism and tau haplotype in the Polish population Neurosci Lett 348 163 166 10.1016/S0304-3940(03)00788-2 12932819 (Pubitemid 36976831)
69. C Zekanowski B Peplonska M Styczynska K Gustaw J Kuznicki M Barcikowska 2003 Mutation screening of the MAPT and STH genes in Polish patients with clinically diagnosed frontotemporal dementia Dement Geriatr Cogn Disord 16 126 131 10.1159/000070999 12826737 (Pubitemid 36736997)
70. M Baker I Litvan H Houlden J Adamson D Dickson J Perez-Tur J Hardy T Lynch E Bigio M Hutton 1999 Association of an extended haplotype in the tau gene with progressive supranuclear palsy Hum Mol Genet 8 711 715 10.1093/hmg/8.4.711 10072441 (Pubitemid 29139987)
71. C Conrad A Andreadis JQ Trojanowski DW Dickson D Kang X Chen W Wiederholt L Hansen E Masliah LJ Thal R Katzman Y Xia T Saitoh 1997 Genetic evidence for the involvement of tau in progressive supranuclear palsy Ann Neurol 41 277 281 10.1002/ana.410410222 9029080 (Pubitemid 27082112)
72. WK Liu TV Le J Adamson M Baker N Cookson J Hardy M Hutton SH Yen DW Dickson 2001 Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy Ann Neurol 50 494 502 10.1002/ana.1159 11601500 (Pubitemid 32938894)
73. H Houlden M Baker HR Morris N MacDonald S Pickering-Brown J Adamson AJ Lees MN Rossor NP Quinn A Kertesz MN Khan J Hardy PL Lantos P St George-Hyslop DG Munoz D Mann AE Lang C Bergeron EH Bigio I Litvan KP Bhatia D Dickson NW Wood M Hutton 2001 Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype Neurology 56 1702 1706 11425937 (Pubitemid 32574570)
74. AM Pittman AJ Myers J Duckworth L Bryden M Hanson P Abou-Sleiman NW Wood J Hardy A Lees R de Silva 2004 The structure of the tau haplotype in controls and in progressive supranuclear palsy Hum Mol Genet 13 1267 1274 10.1093/hmg/ddh138 15115761 (Pubitemid 38877880)
75. JB Kwok ET Teber C Loy M Hallupp G Nicholson GD Mellick DD Buchanan PA Silburn PR Schofield 2004 Tau haplotypes regulate transcription and are associated with Parkinson's disease Ann Neurol 55 329 334 10.1002/ana.10826 14991810 (Pubitemid 38269584)
76. L Skipper K Wilkes M Toft M Baker S Lincoln M Hulihan OA Ross M Hutton J Aasly M Farrer 2004 Linkage disequilibrium and association of MAPT H1 in Parkinson disease Am J Hum Genet 75 669 677 10.1086/424492 15297935 (Pubitemid 39244781)
77. J Zhang Y Song H Chen D Fan 2005 The tau gene haplotype h1 confers a susceptibility to Parkinson's disease Eur Neurol 53 15 21 10.1159/000082956 15627775 (Pubitemid 40522826)